BSTC Financial Facts

Income tax benefit (expense): -735.74K
Diluted net income (loss) per share: 0.2
See Full Income Statement

Accounts payable and accrued expenses: 517.23K
Deferred revenue: 62.55K
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date 2/11/15 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +28.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/10/14 Q314 $0.21$0.19 +$0.02$4M$4M N/A Details
8/11/14 Q214 $0.09$0.12 -$0.03$2.7M$2.91M N/A Details
5/8/14 Q114 $0.12$0.07 +$0.05$2.8M$2.46M N/A Details
8/9/12 Q212 $0.11$0.07 +$0.04$2.6M$2.5M N/A Details
3/9/12 Q411 $0.01N/A N/A $2.6M$1.1M N/A Details
11/8/11 Q311 $0.04N/A N/A $1.9M$1M N/A Details
3/11/11 Q410 $0.02-$0.04 +$0.06$1.1M$1.38M N/A Details